Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.384
Neutral
RSI(14)
48.618
Neutral
STOCH(KDJ)(9,3,3)
64.259
Buy
ATR(14)
8.413
High Vlolatility
CCI(14)
4.905
Neutral
Williams %R
42.300
Buy
TRIX(12,20)
-0.144
Sell
StochRSI(14)
100.000
Overbought
Chemed Corp
CHE430.060USD
0.000
Close 12/15, 16:00（ET）Quotes delayed by 15 min
6.07BMarket Cap
22.59P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Chemed Corp
Currency: USD Updated: 2025-12-12Key Insights
Chemed Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 7/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 574.25.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Chemed Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
4
analysts
Strong Buy
Current Rating
574.250
Target Price
+39.21%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Chemed Corp Highlights
StrengthsRisks
Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 2.43B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 8.97%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 8.97%.
Undervalued
The company’s latest PE is 22.59, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 14.40M shares, decreasing 0.00% quarter-over-quarter.
Held by Ray Dalio
Star Investor Ray Dalio holds 4.53K shares of this stock.
Financial Health
Currency: USD Updated: 2025-12-12The current financial score of Chemed Corp is 9.05, ranking 7/78 in the Healthcare Providers & Services industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 624.90M, representing a year-over-year increase of 3.09%, while its net profit experienced a year-over-year increase of 15.23%.
Score
Financials
8.64
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
8.38
Operational Efficiency
9.11
Growth Potential
9.46
Shareholder Returns
9.66
Chemed Corp's Company Valuation
Currency: USD Updated: 2025-12-12The current valuation score of Chemed Corp is 5.07, ranking 76/78 in the Healthcare Providers & Services industry. Its current P/E ratio is 22.59, which is 65.55% below the recent high of 37.40 and 6.96% above the recent low of 21.02.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 7/78
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-12The current earnings forecast score of Chemed Corp is 9.50, ranking 1/78 in the Healthcare Providers & Services industry. The average price target for Chemed Corp is 576.00, with a high of 595.00 and a low of 550.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
4
analysts
Strong Buy
Current Rating
574.250
Target Price
+39.21%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
65
Total
7
Median
9
Average
Company name
Ratings
Analysts
Chemed Corp
CHE
4
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
27
Tenet Healthcare Corp
THC
24
Universal Health Services Inc
UHS
22
1
2
3
...
13
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-12The current price momentum score of Chemed Corp is 7.36, ranking 41/78 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 447.92 and the support level at 411.34, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
427.116
Buy
MA10
425.472
Buy
MA20
430.936
Sell
MA50
435.600
Sell
MA100
442.220
Sell
MA200
500.139
Sell
Institutional Confidence
Currency: USD Updated: 2025-12-12The current institutional shareholding score of Chemed Corp is 10.00, ranking 1/78 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 111.91%, representing a quarter-over-quarter decrease of 0.17%. The largest institutional shareholder is The Vanguard, holding a total of 1.53M shares, representing 10.84% of shares outstanding, with 3.18% decrease in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
Kayne Anderson Rudnick Investment Management, LLC
State Street Investment Management (US)
Neuberger Berman, LLC
JP Morgan Asset Management
William Blair Investment Management, LLC
Geode Capital Management, L.L.C.
Epoch Investment Partners, Inc.
TD Asset Management Inc.
1
2
Risk Assessment
Currency: USD Updated: 2025-12-12The current risk assessment score of Chemed Corp is 9.18, ranking 5/78 in the Healthcare Providers & Services industry. The company's beta value is 0.44. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.44
VaR
+2.10%
240-Day Maximum Drawdown
+33.42%
240-Day Volatility
+30.73%
Return
Best Daily Return
60 days
+6.06%
120 days
+6.06%
5 years
+9.32%
Worst Daily Return
60 days
-5.09%
120 days
-12.95%
5 years
-12.95%
Sharpe Ratio
60 days
-0.88
120 days
-1.43
5 years
+0.13
Risk Assessment
Maximum Drawdown
240 days
+33.42%
3 years
+36.64%
5 years
+36.64%
Return-to-Drawdown Ratio
240 days
-0.55
3 years
-0.14
5 years
+0.00
Skewness
240 days
-1.79
3 years
-1.74
5 years
-1.15
Volatility
Realised Volatility
240 days
+30.73%
5 years
+24.66%
Standardised True Range
240 days
+2.80%
5 years
+2.45%
Downside Risk-Adjusted Return
120 days
-143.23%
240 days
-143.23%
Maximum Daily Upside Volatility
60 days
+21.11%
Maximum Daily Downside Volatility
60 days
+16.88%
Liquidity
Average Turnover Rate
60 days
+1.22%
120 days
+1.06%
5 years
--
Turnover Deviation
20 days
+68.16%
60 days
+74.16%
120 days
+50.91%
Peer Comparison
Healthcare Providers & Services
Chemed Corp
CHE
8.31 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Alignment Healthcare Inc
ALHC
8.81 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Natera Inc
NTRA
8.51 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lifestance Health Group Inc
LFST
8.51 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cigna Group
CI
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Option Care Health Inc
OPCH
8.45 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Chemed Corp?
The TradingKey Stock Score provides a comprehensive assessment of Chemed Corp based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Chemed Corp’s performance and outlook.
How do we generate the financial health score of Chemed Corp?
To generate the financial health score of Chemed Corp, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Chemed Corp's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Chemed Corp.
How do we generate the company valuation score of Chemed Corp?
To generate the company valuation score of Chemed Corp, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Chemed Corp’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Chemed Corp’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Chemed Corp.
How do we generate the earnings forecast score of Chemed Corp?
To calculate the earnings forecast score of Chemed Corp, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Chemed Corp’s future.
How do we generate the price momentum score of Chemed Corp?
When generating the price momentum score for Chemed Corp, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Chemed Corp’s prices. A higher score indicates a more stable short-term price trend for Chemed Corp.
How do we generate the institutional confidence score of Chemed Corp?
To generate the institutional confidence score of Chemed Corp, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Chemed Corp’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Chemed Corp.
How do we generate the risk management score of Chemed Corp?
To assess the risk management score of Chemed Corp, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Chemed Corp’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Chemed Corp.
